Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


1 Am Heart J
4 Am J Cardiol
2 Eur Heart J
1 Heart
2 Int J Cardiol
2 J Am Coll Cardiol
1 J Card Fail
1 J Cardiovasc Pharmacol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. CHOUAIRI F, Pinsker B, Miller PE, Fudim M, et al
    Effects of COVID-19 on Heart Failure Admissions.
    Am Heart J. 2023 May 6:S0002-8703(23)00111-4. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available

    Am J Cardiol

    Atrial Fibrillation and Heart Failure: Is It the Chicken or the Egg?
    Am J Cardiol. 2023 May 5:S0002-9149(23)00209.

  3. MEYER M, Wetmore JB, Weinhandl ED, Roetker NS, et al
    Association of Nondihydropyridine Calcium Channel Blockers Versus beta-Adrenergic Receptor Blockers With Risk of Heart Failure Hospitalization.
    Am J Cardiol. 2023 May 5:S0002-9149(23)00211.
    PubMed         Abstract available

  4. LLOYD M, Amos ME, Milfred-Laforest S, Motairek IK, et al
    Residing in a Food Desert and Adverse Cardiovascular Events in US Veterans With Established Cardiovascular Disease.
    Am J Cardiol. 2023;196:70-76.
    PubMed         Abstract available

  5. MUKHERJEE M, Ogunmoroti O, Jani V, Kapoor K, et al
    Characteristics of Right Ventricular to Pulmonary Arterial Coupling and Association With Functional Status Among Older Aged Adults from the Multi-Ethnic Study of Atherosclerosis.
    Am J Cardiol. 2023;196:41-51.
    PubMed         Abstract available

    Eur Heart J

  6. Corrigendum to: Reduced lean body mass: a potential modifiable contributor to the pathophysiology of heart failure.
    Eur Heart J. 2023 May 8:ehad272. doi: 10.1093.

  7. SHEMESH E, Chevli PA, Islam T, German CA, et al
    Circulating ketone bodies and cardiovascular outcomes: the MESA study.
    Eur Heart J. 2023 Mar 6:ehad087. doi: 10.1093.
    PubMed         Abstract available


  8. MORTON G, Moore J
    Systems of care for heart failure: bridging the divide between primary care and specialist services.
    Heart. 2023 May 5:heartjnl-2022-321757. doi: 10.1136/heartjnl-2022-321757.

    Int J Cardiol

  9. MELENDO-VIU M, Dobarro D, Lopez AM, Dominguez LM, et al
    Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?
    Int J Cardiol. 2023 May 9:S0167-5273(23)00658.
    PubMed         Abstract available

  10. MAGRI D, Palermo P, Salvioni E, Mapelli M, et al
    Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2023 May 8:S0167-5273(23)00659.
    PubMed         Abstract available

    J Am Coll Cardiol

  11. KRISTENSEN SL, Jensen J, Schou M
    SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease: Jigsaw Falling Into Place.
    J Am Coll Cardiol. 2023;81:1915-1917.

  12. BUTLER J, Packer M, Siddiqi TJ, Bohm M, et al
    Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.
    J Am Coll Cardiol. 2023;81:1902-1914.
    PubMed         Abstract available

    J Card Fail

  13. OBOKATA M, Sorimachi H, Harada T, Kagami K, et al
    Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan.
    J Card Fail. 2023;29:375-388.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  14. KUANG N, Shu B, Yang F, Li S, et al
    TRAIL or TRAIL-R2 as a predictive biomarker for mortality or cardiovascular events: A systematic review and meta-analysis.
    J Cardiovasc Pharmacol. 2023 Mar 9. doi: 10.1097/FJC.0000000000001415.
    PubMed         Abstract available

    PLoS One

  15. SIVAKUMAR B, Lemonde M, Stein M, Mak S, et al
    Patient perspectives on the use of mobile apps to support heart failure management: A qualitative descriptive study.
    PLoS One. 2023;18:e0285659.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.